Our Science – Onda Website
Masanori Onda, M.D., Ph.D.
|
Biography
Dr. Onda is Staff Scientist of the Laboratory Molecular Biology, Center for Cancer Research. He obtained his M.D. in 1989. He obtained Ph.D. from The University of Tokyo in 1997. He received medical training (Orthopedic surgery) at The University of Tokyo, Hitachi General Hospital, and Mitsui Memorial Hospital. He received research training at The Institute of Medical Science University of Tokyo and NIH.
Research
New approach to Cancer Treatment: Recombinant Immunotoxins
Reducing immunogenicity of PE38 based immunotoxins
New Target for Mesothelioma and Gynecological Malignancies: Mesothelin
Soluble mesothelin is useful biomarker for mesothelioma
New antibody for mesothelin
Investigating new molecular target for immunotoxin (CAPC, PATE etc)
New Target for Osteosarcoma and neuroblastoma
8H9 immunotoxin
New Target for lympoma
CD30 immunotoxin,
CD30 antibody which does not bind shedding epitopes
This page was last updated on 7/15/2008.